Annals of Internal Medicine tracks early oral semaglutide uptake for obesity

The wire

1. 01Investigators report early uptake of oral semaglutide for obesity treatment after its regulatory approval, published in Annals of Internal Medicine.
2. 02Prescribers and telehealth operators watching whether an oral incretin shifts volume away from injectables will want the uptake curve.
3. 03Only the title and authorship are available here; the magnitude of uptake, data source and time window are not detailed in the material at hand.

From the source

Early Uptake of Oral Semaglutide for Obesity Treatment After Regulatory Approval

Annals of internal medicine · 2026 Oct 13 · Jelwan Y, Zahid S, Burka S et al.